Dialysis Industry to Face Regulatory Scrutiny in 2021, Driven by Kidney-care Models, Medicare Advantage
May 6, 2021 — Capstone believes kidney care—namely DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. (FMS)—will come under regulatory scrutiny in 2021 due to the launch of recent value-based care models, an aging population, Medicare Advantage coverage...
COVID-19 State Reopening Tracker
Winter is coming, and with it, another wave of new Coronavirus cases October 1, 2020 – Capstone believes states removing restrictions on indoor gatherings, entering the fall season, will lead to a third wave of new COVID-19 cases by November, possibly coinciding...
Opioid Litigation Focus Will Shift to Chain Pharmacies
Walgreens, CVS, Rite Aid, and Walmart face $30 billion-35 billion in liabilities. August 14, 2020 – Capstone believes the focus of state attorneys general and municipalities opioid litigation will shift to chain pharmacies—primarily Walgreens Boots Alliance Inc....
Emerging Privacy Legislation and its Risks to a Healthcare Tech Company’s Business Model
The Request: Capstone advised a client on the potential acquisition of a healthcare analytics company that paired bolstered, value-added overlays to healthcare provider contact data. Specifically, we analyzed regulation, legislation, and other government initiatives...
